
NYSEHealthcareMedical - Diagnostics & Research
最新資料
US$435.84
−US$0.59 · -0.14%
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
前收盤價
US$435.84
−US$0.59 · -0.14%
盤前
US$435.8
−US$0.04 · -0.01%
10月8日 上午7:33 ET
盤中時間採用ET。市場資料可能有所延遲。
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
日內區間
目前US$435.84
52週區間
目前US$435.84
盤中時間採用ET。市場資料可能有所延遲。
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
日內區間
目前US$435.84
52週區間
目前US$435.84
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 31.65億 USD | 29.58億 USD | 29.56億 USD | 29.72億 USD | 27.86億 USD |
| 銷貨成本 | 13.37億 USD | 12億 USD | 11.95億 USD | 12.48億 USD | 11.57億 USD |
| 毛利 | 18.29億 USD | 17.58億 USD | 17.61億 USD | 17.24億 USD | 16.29億 USD |
| 研究與開發 | 1.95億 USD | 1.83億 USD | 1.75億 USD | 1.76億 USD | 1.68億 USD |
| 銷售、一般及管理費用 | 7.4億 USD | 6.9億 USD | 7.36億 USD | 6.58億 USD | 6.27億 USD |
| 營業費用 | 9.35億 USD | 9.32億 USD | 9.44億 USD | 8.5億 USD | 8.08億 USD |
| 利息收入 | 738.9萬 USD | 1741.6萬 USD | 1662.1萬 USD | 1102萬 USD | 1222.1萬 USD |
| 利息支出 | 6954.8萬 USD | 8967.7萬 USD | 9886.1萬 USD | 4879.7萬 USD | 4493.8萬 USD |
| 折舊和攤銷 | 2.06億 USD | 1.92億 USD | 1.66億 USD | 1.3億 USD | 1.32億 USD |
| 營業利益 | 8.93億 USD | 8.26億 USD | 8.18億 USD | 8.73億 USD | 8.22億 USD |
| 淨利 | 6.43億 USD | 6.38億 USD | 6.42億 USD | 7.08億 USD | 6.93億 USD |
公司資料更新於 2026年10月8日。
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$453.5
上漲空間 4.05%報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T825.23億0.06%129.41兆 JPY0.09%¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI12.94億0.06%2.3兆 USD0.03%US$381.03-0.40%
Vanguard S&P 500 ETFVOO10.82億0.06%1.8兆 USD0.03%US$714.34-0.26%
Vanguard Morningstar Mid-Cap ETFVO8.81億0.39%2264億 USD0.03%US$80.14-1.04%
iShares Core S&P 500 ETFIVV5.71億0.06%8996.25億 USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY5.21億0.06%8190.39億 USD0.09%US$777.22-0.24%
Vanguard Morningstar Mid-Cap Growth ETFVOT3.13億0.91%341億 USD0.05%US$300.18-1.27%
State Street Health Care Select Sector SPDR ETFXLV3.05億0.71%431.09億 USD0.08%US$168.81+1.03%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Mid-Cap Growth ETFVOT
State Street Health Care Select Sector SPDR ETFXLVAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。